Lemaitre Vasculr Financials
This page shows Lemaitre Vasculr (LMAT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Margin expansion and cash conversion show LeMaitre turning added sales into profit faster than its cost base is rising.
From FY2023 to FY2025, gross margin rose from65.7% to71.5% , so each sales dollar carried materially more profit before overhead. At the same time, free cash flow margin moved from15.2% to29.8% even as the balance sheet stayed larger after FY2024, showing the profit step-up was also becoming spendable cash rather than just accounting income.
FY2025 operating margin reached
The balance sheet is extremely liquid at 12.9x current ratio, so near-term obligations do not appear to be the operating constraint. But it is not the same low-liability company it was before FY2024: total liabilities remain
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Lemaitre Vasculr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Lemaitre Vasculr has an operating margin of 27.2%, meaning the company retains $27 of operating profit per $100 of revenue. This strong profitability earns a score of 77/100, reflecting efficient cost management and pricing power. This is up from 23.8% the prior year.
Lemaitre Vasculr's revenue grew 13.5% year-over-year to $249.6M, a solid pace of expansion. This earns a growth score of 56/100.
Lemaitre Vasculr carries a low D/E ratio of 0.56, meaning only $0.56 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 12.89, Lemaitre Vasculr holds $12.89 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Lemaitre Vasculr converts 29.8% of revenue into free cash flow ($74.5M). This strong cash generation earns a score of 83/100.
Lemaitre Vasculr's ROE of 14.7% shows moderate profitability relative to equity, earning a score of 41/100. This is up from 13.1% the prior year.
Lemaitre Vasculr scores 7.73, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.1B) relative to total liabilities ($222.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Lemaitre Vasculr passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Lemaitre Vasculr generates $1.41 in operating cash flow ($81.3M OCF vs $57.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Lemaitre Vasculr earns $13.1 in operating income for every $1 of interest expense ($67.9M vs $5.2M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Lemaitre Vasculr generated $249.6M in revenue in fiscal year 2025. This represents an increase of 13.5% from the prior year.
Lemaitre Vasculr's EBITDA was $78.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 26.6% from the prior year.
Lemaitre Vasculr reported $57.7M in net income in fiscal year 2025. This represents an increase of 31.1% from the prior year.
Lemaitre Vasculr earned $2.52 per diluted share (EPS) in fiscal year 2025. This represents an increase of 30.6% from the prior year.
Cash & Balance Sheet
Lemaitre Vasculr generated $74.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 100.4% from the prior year.
Lemaitre Vasculr held $28.2M in cash against $0 in long-term debt as of fiscal year 2025.
Lemaitre Vasculr paid $0.80 per share in dividends in fiscal year 2025. This represents an increase of 25.0% from the prior year.
Lemaitre Vasculr had 23M shares outstanding in fiscal year 2025. This represents an increase of 1.0% from the prior year.
Margins & Returns
Lemaitre Vasculr's gross margin was 71.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.9 percentage points from the prior year.
Lemaitre Vasculr's operating margin was 27.2% in fiscal year 2025, reflecting core business profitability. This is up 3.4 percentage points from the prior year.
Lemaitre Vasculr's net profit margin was 23.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.1 percentage points from the prior year.
Lemaitre Vasculr's ROE was 14.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.6 percentage points from the prior year.
Capital Allocation
Lemaitre Vasculr invested $14.1M in research and development in fiscal year 2025. This represents a decrease of 9.7% from the prior year.
Lemaitre Vasculr spent $1.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 5.9% from the prior year.
Lemaitre Vasculr invested $6.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 2.6% from the prior year.
LMAT Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $66.6M+3.3% | $64.5M+5.6% | $61.0M-5.0% | $64.2M+7.3% | $59.9M+7.5% | $55.7M+1.6% | $54.8M-1.8% | $55.8M |
| Cost of Revenue | $18.2M-0.6% | $18.3M+21.0% | $15.1M-21.6% | $19.3M+4.4% | $18.5M+7.7% | $17.1M-2.9% | $17.6M+1.5% | $17.4M |
| Gross Profit | $48.4M+4.8% | $46.2M+0.5% | $46.0M+2.2% | $45.0M+8.6% | $41.4M+7.3% | $38.6M+3.8% | $37.2M-3.4% | $38.5M |
| R&D Expenses | $4.1M+14.9% | $3.5M+19.0% | $3.0M-16.1% | $3.5M-13.5% | $4.1M+13.2% | $3.6M-1.0% | $3.7M-14.7% | $4.3M |
| SG&A Expenses | $12.0M+15.9% | $10.4M-3.3% | $10.8M+3.4% | $10.4M-0.9% | $10.5M+10.5% | $9.5M+6.3% | $8.9M+1.3% | $8.8M |
| Operating Income | $17.8M-5.6% | $18.8M-7.3% | $20.3M+25.8% | $16.1M+27.8% | $12.6M-1.8% | $12.9M-2.2% | $13.1M-8.6% | $14.4M |
| Interest Expense | $1.3M+0.2% | $1.3M+0.1% | $1.3M-0.2% | $1.3M+0.7% | $1.3M+529.3% | $205K | $0 | $0 |
| Income Tax | $4.0M-15.4% | $4.7M-9.5% | $5.2M+21.4% | $4.3M+32.8% | $3.2M+13.9% | $2.8M-16.8% | $3.4M-7.3% | $3.7M |
| Net Income | $15.7M+0.8% | $15.5M-10.4% | $17.4M+26.0% | $13.8M+25.1% | $11.0M-1.2% | $11.1M0.0% | $11.1M-5.8% | $11.8M |
| EPS (Diluted) | $0.68 | N/A | $0.75+25.0% | $0.60+25.0% | $0.48 | N/A | $0.49-5.8% | $0.52 |
LMAT Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $629.5M+2.2% | $615.7M+2.9% | $598.1M+3.5% | $577.6M+3.9% | $556.0M+0.8% | $551.8M+46.4% | $377.0M+3.8% | $363.1M |
| Current Assets | $477.8M+2.0% | $468.2M+3.6% | $452.0M+5.1% | $430.1M+5.4% | $408.1M+1.5% | $402.2M+77.1% | $227.1M+6.7% | $212.8M |
| Cash & Equivalents | $26.9M-4.9% | $28.2M+10.8% | $25.5M-6.2% | $27.2M+7.2% | $25.3M-1.1% | $25.6M+21.9% | $21.0M-5.7% | $22.3M |
| Inventory | $34.9M+1.3% | $34.4M-5.1% | $36.3M+8.3% | $33.5M-1.3% | $33.9M-2.2% | $34.7M+2.6% | $33.8M-2.1% | $34.5M |
| Accounts Receivable | $35.8M+6.4% | $33.6M+3.7% | $32.4M-11.3% | $36.5M+4.1% | $35.1M+16.8% | $30.1M-6.8% | $32.3M+4.7% | $30.8M |
| Goodwill | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M0.0% | $65.9M |
| Total Liabilities | $222.9M+0.3% | $222.2M+1.4% | $219.1M+2.0% | $214.9M+3.1% | $208.4M-2.8% | $214.5M+366.9% | $46.0M+5.5% | $43.5M |
| Current Liabilities | $33.4M-8.1% | $36.3M+9.1% | $33.3M+8.0% | $30.8M+24.5% | $24.7M-19.2% | $30.6M+4.3% | $29.3M+15.3% | $25.4M |
| Long-Term Debt | $168.9M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $406.6M+3.3% | $393.5M+3.9% | $378.9M+4.5% | $362.7M+4.3% | $347.6M+3.0% | $337.3M+1.9% | $331.1M+3.6% | $319.5M |
| Retained Earnings | $194.7M+5.4% | $184.7M+6.4% | $173.7M+8.0% | $160.8M+6.1% | $151.6M+4.5% | $145.1M+5.5% | $137.5M+5.8% | $130.0M |
LMAT Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.1M-34.8% | $23.2M-19.5% | $28.8M+41.8% | $20.3M+124.5% | $9.0M-40.5% | $15.2M+6.6% | $14.2M+48.0% | $9.6M |
| Capital Expenditures | $2.8M+56.6% | $1.8M-22.1% | $2.3M+70.0% | $1.3M-3.0% | $1.4M-32.3% | $2.0M+22.4% | $1.7M-11.1% | $1.9M |
| Free Cash Flow | $12.3M-42.4% | $21.4M-19.3% | $26.5M+39.8% | $18.9M+147.5% | $7.7M-41.7% | $13.1M+4.5% | $12.6M+62.3% | $7.7M |
| Investing Cash Flow | -$13.1M+22.0% | -$16.8M+38.7% | -$27.4M-67.9% | -$16.3M-278.4% | -$4.3M+97.5% | -$173.9M-1251.8% | -$12.9M-16.9% | -$11.0M |
| Financing Cash Flow | -$3.2M+10.3% | -$3.6M-21.6% | -$3.0M-6.7% | -$2.8M+47.2% | -$5.2M-103.2% | $164.1M+5312.2% | -$3.1M-9.7% | -$2.9M |
| Dividends Paid | $5.7M+25.9% | $4.5M0.0% | $4.5M+0.3% | $4.5M+0.1% | $4.5M+25.5% | $3.6M+0.1% | $3.6M+0.1% | $3.6M |
| Share Buybacks | $460K-62.2% | $1.2M | $0-100.0% | $4K-99.3% | $601K-55.6% | $1.4M+135200.0% | $1K-85.7% | $7K |
LMAT Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.7%+1.1pp | 71.7%-3.6pp | 75.3%+5.3pp | 70.0%+0.8pp | 69.2%-0.1pp | 69.3%+1.4pp | 67.8%-1.1pp | 68.9% |
| Operating Margin | 26.7%-2.5pp | 29.2%-4.0pp | 33.3%+8.1pp | 25.1%+4.0pp | 21.1%-2.0pp | 23.1%-0.9pp | 24.0%-1.8pp | 25.8% |
| Net Margin | 23.6%-0.6pp | 24.1%-4.3pp | 28.4%+7.0pp | 21.4%+3.1pp | 18.4%-1.6pp | 20.0%-0.3pp | 20.3%-0.9pp | 21.2% |
| Return on Equity | 3.9%-0.1pp | 4.0%-0.6pp | 4.6%+0.8pp | 3.8%+0.6pp | 3.2%-0.1pp | 3.3%-0.1pp | 3.4%-0.3pp | 3.7% |
| Return on Assets | 2.5%-0.0pp | 2.5%-0.4pp | 2.9%+0.5pp | 2.4%+0.4pp | 2.0%-0.0pp | 2.0%-0.9pp | 2.9%-0.3pp | 3.3% |
| Current Ratio | 14.32+1.4 | 12.89-0.7 | 13.58-0.4 | 13.96-2.5 | 16.49+3.4 | 13.14+5.4 | 7.74-0.6 | 8.36 |
| Debt-to-Equity | 0.55-0.0 | 0.56-0.0 | 0.58-0.0 | 0.590.0 | 0.60-0.0 | 0.64+0.5 | 0.140.0 | 0.14 |
| FCF Margin | 18.5%-14.7pp | 33.2%-10.2pp | 43.4%+13.9pp | 29.5%+16.7pp | 12.8%-10.8pp | 23.6%+0.6pp | 22.9%+9.1pp | 13.9% |
Similar Companies
Frequently Asked Questions
What is Lemaitre Vasculr's annual revenue?
Lemaitre Vasculr (LMAT) reported $249.6M in total revenue for fiscal year 2025. This represents a 13.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Lemaitre Vasculr's revenue growing?
Lemaitre Vasculr (LMAT) revenue grew by 13.5% year-over-year, from $219.9M to $249.6M in fiscal year 2025.
Is Lemaitre Vasculr profitable?
Yes, Lemaitre Vasculr (LMAT) reported a net income of $57.7M in fiscal year 2025, with a net profit margin of 23.1%.
What is Lemaitre Vasculr's EBITDA?
Lemaitre Vasculr (LMAT) had EBITDA of $78.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Lemaitre Vasculr's gross margin?
Lemaitre Vasculr (LMAT) had a gross margin of 71.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Lemaitre Vasculr's operating margin?
Lemaitre Vasculr (LMAT) had an operating margin of 27.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Lemaitre Vasculr's net profit margin?
Lemaitre Vasculr (LMAT) had a net profit margin of 23.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Lemaitre Vasculr pay dividends?
Yes, Lemaitre Vasculr (LMAT) paid $0.80 per share in dividends during fiscal year 2025.
What is Lemaitre Vasculr's return on equity (ROE)?
Lemaitre Vasculr (LMAT) has a return on equity of 14.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Lemaitre Vasculr's free cash flow?
Lemaitre Vasculr (LMAT) generated $74.5M in free cash flow during fiscal year 2025. This represents a 100.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Lemaitre Vasculr's operating cash flow?
Lemaitre Vasculr (LMAT) generated $81.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Lemaitre Vasculr's total assets?
Lemaitre Vasculr (LMAT) had $615.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Lemaitre Vasculr's capital expenditures?
Lemaitre Vasculr (LMAT) invested $6.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Lemaitre Vasculr spend on research and development?
Lemaitre Vasculr (LMAT) invested $14.1M in research and development during fiscal year 2025.
What is Lemaitre Vasculr's current ratio?
Lemaitre Vasculr (LMAT) had a current ratio of 12.89 as of fiscal year 2025, which is generally considered healthy.
What is Lemaitre Vasculr's debt-to-equity ratio?
Lemaitre Vasculr (LMAT) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Lemaitre Vasculr's return on assets (ROA)?
Lemaitre Vasculr (LMAT) had a return on assets of 9.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Lemaitre Vasculr's Altman Z-Score?
Lemaitre Vasculr (LMAT) has an Altman Z-Score of 7.73, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Lemaitre Vasculr's Piotroski F-Score?
Lemaitre Vasculr (LMAT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Lemaitre Vasculr's earnings high quality?
Lemaitre Vasculr (LMAT) has an earnings quality ratio of 1.41x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Lemaitre Vasculr cover its interest payments?
Lemaitre Vasculr (LMAT) has an interest coverage ratio of 13.1x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Lemaitre Vasculr?
Lemaitre Vasculr (LMAT) scores 74 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.